Mr. Marchessault developed a unique Department of Defense Commercialization/Technology Transfer Program (C/T2) with a holistic approach leveraging federal investment with private sector capital to commercialize federal medical R&D technologies. The core of the C/T2 Program structured to provide tools and programs to; Assess Commercial Viability, Market federally funded R&D and promote the Economic Impact in the Healthcare Market, DoD and State and Federal Governments resulted in quantifiable outcome measures and is continuously seeking tools and methods to improve the program.